Timing Exercise Training as Strategy to Improve Insulin Sensitivity and Substrate Metabolism in Men and Woman With Pre-diabetes
Conditions: Pre-diabetes; Overweight and Obesity Intervention: Behavioral: Timing of exercise Sponsor: Maastricht University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
